97 related articles for article (PubMed ID: 11816012)
1. Investigation of the pharmacokinetics of celecoxib by liquid chromatography-mass spectrometry.
Werner U; Werner D; Pahl A; Mundkowski R; Gillich M; Brune K
Biomed Chromatogr; 2002 Feb; 16(1):56-60. PubMed ID: 11816012
[TBL] [Abstract][Full Text] [Related]
2. Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2.
Kirchheiner J; Meineke I; Freytag G; Meisel C; Roots I; Brockmöller J
Clin Pharmacol Ther; 2002 Jul; 72(1):62-75. PubMed ID: 12152005
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetic of celecoxib in healthy Thai volunteers.
Itthipanichpong C; Chompootaweep S; Wittayalertpanya S; Kemsri W; Thaworn N; Lilitkarntrakul P; Parikamsil S
J Med Assoc Thai; 2005 May; 88(5):632-8. PubMed ID: 16149679
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
5. Quantification of nimesulide in human plasma by high-performance liquid chromatography/tandem mass spectrometry. Application to bioequivalence studies.
Barrientos-Astigarraga RE; Vannuchi YB; Sucupira M; Moreno RA; Muscará MN; De Nucci G
J Mass Spectrom; 2001 Dec; 36(12):1281-6. PubMed ID: 11754119
[TBL] [Abstract][Full Text] [Related]
6. Influence of age and cytochrome P450 2C9 genotype on the steady-state disposition of diclofenac and celecoxib.
Brenner SS; Herrlinger C; Dilger K; Mürdter TE; Hofmann U; Marx C; Klotz U
Clin Pharmacokinet; 2003; 42(3):283-92. PubMed ID: 12603175
[TBL] [Abstract][Full Text] [Related]
7. In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics.
Tang C; Shou M; Rushmore TH; Mei Q; Sandhu P; Woolf EJ; Rose MJ; Gelmann A; Greenberg HE; De Lepeleire I; Van Hecken A; De Schepper PJ; Ebel DL; Schwartz JI; Rodrigues AD
Pharmacogenetics; 2001 Apr; 11(3):223-35. PubMed ID: 11337938
[TBL] [Abstract][Full Text] [Related]
8. Selective and rapid liquid chromatography-mass spectrometry method for the quantification of rofecoxib in pharmacokinetic studies with humans.
Werner U; Werner D; Mundkowski R; Gillich M; Brune K
J Chromatogr B Biomed Sci Appl; 2001 Aug; 760(1):83-90. PubMed ID: 11522069
[TBL] [Abstract][Full Text] [Related]
9. Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers.
Kirchheiner J; Brockmöller J; Meineke I; Bauer S; Rohde W; Meisel C; Roots I
Clin Pharmacol Ther; 2002 Apr; 71(4):286-96. PubMed ID: 11956512
[TBL] [Abstract][Full Text] [Related]
10. High performance liquid chromatographic determination of cox-2 inhibitor rofecoxib in human plasma.
Mandal U; Ganesan M; Jayakumar M; Pal TK; Chattaraj TK; Ray K; Banerjee SN
J Indian Med Assoc; 2003 Aug; 101(8):486-8. PubMed ID: 15071803
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humans.
Werner U; Werner D; Rau T; Fromm MF; Hinz B; Brune K
Clin Pharmacol Ther; 2003 Aug; 74(2):130-7. PubMed ID: 12891223
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 2C9 genotype: impact on celecoxib safety and pharmacokinetics in a pediatric patient.
Stempak D; Bukaveckas BL; Linder M; Koren G; Baruchel S
Clin Pharmacol Ther; 2005 Sep; 78(3):309-10. PubMed ID: 16153401
[No Abstract] [Full Text] [Related]
13. Determination of tegaserod by LC-ESI-MS/MS and its application to a pharmacokinetic study in healthy Chinese volunteers.
Zou JJ; Bian XJ; Ding L; Zhu YB; Fan HW; Xiao DW
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):151-7. PubMed ID: 18069077
[TBL] [Abstract][Full Text] [Related]
14. Determination of oleanolic acid in human plasma and study of its pharmacokinetics in Chinese healthy male volunteers by HPLC tandem mass spectrometry.
Song M; Hang TJ; Wang Y; Jiang L; Wu XL; Zhang Z; Shen J; Zhang Y
J Pharm Biomed Anal; 2006 Jan; 40(1):190-6. PubMed ID: 16126358
[TBL] [Abstract][Full Text] [Related]
15. Determination of valdecoxib in serum using a HPLC-diode array detector and its application in a pharmacokinetic study.
Keshetty S; Venisetty RK; Molmoori V; Ciddi V
Pharmazie; 2006 Mar; 61(3):245-6. PubMed ID: 16599270
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography/negative ion electrospray tandem mass spectrometry method for the quantification of rosuvastatin in human plasma: application to a pharmacokinetic study.
Gao J; Zhong D; Duan X; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):35-40. PubMed ID: 17560178
[TBL] [Abstract][Full Text] [Related]
17. A liquid chromatography-mass spectrometry method for the quantification of both etoricoxib and valdecoxib in human plasma.
Werner U; Werner D; Hinz B; Lambrecht C; Brune K
Biomed Chromatogr; 2005 Mar; 19(2):113-8. PubMed ID: 15473012
[TBL] [Abstract][Full Text] [Related]
18. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with allopurinol, celecoxib and cimetidine in healthy subjects.
Ayalasomayajula S; Tchaloyan S; Yeh CM; Bizot MN; Dieterich HA; Howard D; Dole WP
Curr Med Res Opin; 2008 Mar; 24(3):717-26. PubMed ID: 18234150
[TBL] [Abstract][Full Text] [Related]
19. Determination of glycyrrhetic acid in human plasma by HPLC-MS method and investigation of its pharmacokinetics.
Zhao WJ; Wang BJ; Wei CM; Yuan GY; Bu FL; Guo RC
J Clin Pharm Ther; 2008 Jun; 33(3):289-94. PubMed ID: 18452416
[TBL] [Abstract][Full Text] [Related]
20. Bromazepam determination in human plasma by high-performance liquid chromatography coupled to tandem mass spectrometry: a highly sensitive and specific tool for bioequivalence studies.
Laurito TL; Mendes GD; Santagada V; Caliendo G; de Moraes ME; De Nucci G
J Mass Spectrom; 2004 Feb; 39(2):168-76. PubMed ID: 14991686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
